Extended Protection against Recurrent VTE
Extended Protection against Recurrent VTE
2021-02-17
Protect your patients from VTE by considering their individual risk factors and providing appropriate extended anticoagulation
© Bayer AG, 2020 | Approval number PP-M_RIVALL-0086-1